Cybin Inc.
HELP
Cybin Inc. Common Stock represents Cybin Inc., a clinical-stage biopharmaceutical company focused on developing psychedelic-based therapeutics for mental health conditions. The company is advancing a pipeline of investigational treatments designed to address psychiatric and neurological disorders, with work centered on proprietary compounds, drug delivery systems, and clinical research programs. Its current activities include late-stage and mid-stage development efforts for therapies targeting major depressive disorder and generalized anxiety disorder, alongside earlier-stage programs exploring additional neuropsychiatric uses. Cybin’s business is rooted in research and development, supported by partnerships and scientific collaborations that help advance its therapeutic platform. The company is headquartered in Toronto, Canada, and operates within the biotechnology and pharmaceutical research sectors, where it is known for its focus on next-generation mental health treatment options.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$171M
▼ -30.8% YoY
Op. Margin
–
ROIC
-48.04%
▼ -0.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$142M
▼ -30.4% YoY
Op. Cash Flow (TTM)
-$141M
▼ -85.4% YoY
Net Debt
-$157M
Net Cash Position
Cash & Equiv.
$157M
Continue Research
Peers
Biotechnology · Pick stocks to compare with HELP
Cybin (HELP) in three numbers
Questions about Cybin
Is Cybin a high-quality business?
Cybin scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$157M, and its weakest is return on capital at -48.0%. The Quality tab shows every check against its target.
Does Cybin (HELP) pay a dividend?
No. Cybin (HELP) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing HELP
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.